LIALDA PACKAGE INSERT PDF

Check out Lialda for induction of remission in active mild to moderate UC and maintenance of UC remission. Read safety info including potential kidney. Shire US Manufacturing Inc.: LIALDA is indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis and for. Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Lialda (mesalamine).

Author: Shakalkree Zuluramar
Country: Equatorial Guinea
Language: English (Spanish)
Genre: Art
Published (Last): 22 May 2014
Pages: 35
PDF File Size: 5.61 Mb
ePub File Size: 10.16 Mb
ISBN: 548-6-67106-955-7
Downloads: 2272
Price: Free* [*Free Regsitration Required]
Uploader: Nikotaur

You must have JavaScript enabled on your computer to access this Web site feature. You may need to adjust your Internet properties packagee your Web browser software, such as Microsoft Internet Explorer or Mozilla Firefox.

For the induction of remission in patients with active, mild to moderate ulcerative colitis UC and for the maintenance of remission of UC. See Full Important Safety Information. See Additional Important Safety Information. Do not take Lialda mesalamine if you are allergic to salicylates, such as aspirin, or medications that contain aspirin; aminosalicylates; mesalamine; or any other ingredients in Lialda. In clinical studies of Lialda, inflammation of the pancreas also occurred. If this happens to you, your doctor may tell you to stop taking Lialda.

Lialda is a prescription medication approved for the induction of remission in patients with active, mild to moderate ulcerative colitis UC and for the maintenance of remission of UC. Please see Full Prescribing Information for Lialda mesalamine. You are encouraged to report negative side effects of prescription drugs to the FDA.

  CZ-V21AP KEYENCE PDF

All content on this Web site, including text, images, graphics, sound files, and their arrangement, belongs to Shire and is protected by international copyright laws.

Ulcerative Colitis (UC) Treatment | Lialda® (mesalamine)

All other intellectual property rights are reserved. The content may not be copied for commercial use or distribution, nor may these objects be downloaded, modified, or posted to other sites. This site is intended solely for US residents and is governed solely by US laws and government regulations. Please see our privacy policy for more information. While Shire US Inc. This link will take you to a Web isnert maintained by a third party, who is responsible for its content and privacy policy. Shire does not control the content of non-Shire Web sites, and this link does not constitute an endorsement by Shire of the site’s content.

Our privacy policy does not apply to this site. We encourage you to read the privacy policy of every Web site you visit. Click “Cancel” to return or “OK” to continue.

E-mail to a Friend

The information contained in this section packagee the site is intended for US health care professionals only. Click OK if you are a health care professional.

  DS2Y S DC12 PDF

E-mail this page or Web site to a friend or loved one by filling out the form below. All fields are required.

Your e-mail address and that of the recipient will be used for transmission only and will not be used for any other purposes.

E—mail this list of questions for the doctor — to yourself, a friend or a loved one — by filling out the form below. Cookies are required to use some elements of this Web site. Following Your Prescribed Treatment Plan.

Talk to your doctor about why Lialda may be right for you. Find information about UC.

Important Safety Information Do not take Lialda mesalamine if you are allergic to salicylates, such as aspirin, or medications that contain aspirin; aminosalicylates; mesalamine; or any other ingredients in Lialda. Tell your doctor if you: Kidney problems have been reported with medications that contain mesalamine, such as Lialda.

Your doctor may check to see how your kidneys are working before starting Lialda and periodically while taking Lialda. E-mail this page only. Please review Shire’s Privacy Policy.